212 related articles for article (PubMed ID: 1671751)
21. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.
Lehtola L; Nistér M; Hölttä E; Westermark B; Alitalo K
Cell Regul; 1991 Aug; 2(8):651-61. PubMed ID: 1685673
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of epidermal growth factor receptors in bladder tumours.
Berger MS; Greenfield C; Gullick WJ; Haley J; Downward J; Neal DE; Harris AL; Waterfield MD
Br J Cancer; 1987 Nov; 56(5):533-7. PubMed ID: 3426916
[TBL] [Abstract][Full Text] [Related]
24. Growth factor receptor and related oncogene determination in mesenchymal tumors.
Duda RB; Cundiff D; August CZ; Wagman LD; Bauer KD
Cancer; 1993 Jun; 71(11):3526-30. PubMed ID: 8098266
[TBL] [Abstract][Full Text] [Related]
25. Expression of the c-erbB-2 protein in normal and transformed cells.
Gullick WJ; Berger MS; Bennett PL; Rothbard JB; Waterfield MD
Int J Cancer; 1987 Aug; 40(2):246-54. PubMed ID: 3301694
[TBL] [Abstract][Full Text] [Related]
26. Quantification of erbB-2/neu levels in tissue.
Paik S; King CR; Simpson S; Lippman ME
Methods Enzymol; 1991; 198():290-300. PubMed ID: 1677445
[No Abstract] [Full Text] [Related]
27. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
Horak E; Smith K; Bromley L; LeJeune S; Greenall M; Lane D; Harris AL
Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
[TBL] [Abstract][Full Text] [Related]
28. Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid.
Soares P; Sambade C; Sobrinho-Simões M
Int J Cancer; 1994 Feb; 56(3):459-61. PubMed ID: 7906256
[No Abstract] [Full Text] [Related]
29. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
30. EGF receptor amplification and expression in human brain tumours.
Chaffanet M; Chauvin C; Lainé M; Berger F; Chédin M; Rost N; Nissou MF; Benabid AL
Eur J Cancer; 1992; 28(1):11-7. PubMed ID: 1567659
[TBL] [Abstract][Full Text] [Related]
31. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
32. Expression of the epidermal growth factor receptor gene in human brain metastases.
Torp SH; Helseth E; Ryan L; Stølan S; Dalen A; Unsgaard G
APMIS; 1992 Aug; 100(8):713-9. PubMed ID: 1520484
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms.
Kraus MH; Popescu NC; Amsbaugh SC; King CR
EMBO J; 1987 Mar; 6(3):605-10. PubMed ID: 3034598
[TBL] [Abstract][Full Text] [Related]
34. Identification and interpretation of epidermal growth factor and c-erbB-2 overexpression.
Gusterson BA
Eur J Cancer; 1992; 28(1):263-7. PubMed ID: 1348953
[TBL] [Abstract][Full Text] [Related]
35. Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs.
King CR; Kraus MH; Williams LT; Merlino GT; Pastan IH; Aaronson SA
Nucleic Acids Res; 1985 Dec; 13(23):8477-86. PubMed ID: 3001641
[TBL] [Abstract][Full Text] [Related]
36. Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
Hubbard AL; Doris CP; Thompson AM; Chetty U; Anderson TJ
Br J Cancer; 1994 Sep; 70(3):434-9. PubMed ID: 7915911
[TBL] [Abstract][Full Text] [Related]
37. Expression of the c-ski proto-oncogene in human melanoma cell lines.
Fumagalli S; Doneda L; Nomura N; Larizza L
Melanoma Res; 1993 Feb; 3(1):23-7. PubMed ID: 8471834
[TBL] [Abstract][Full Text] [Related]
38. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer.
Gullick WJ; Srinivasan R
Breast Cancer Res Treat; 1998; 52(1-3):43-53. PubMed ID: 10066071
[TBL] [Abstract][Full Text] [Related]
39. Oncogene-related growth factors and growth factor receptors in human malignant glioma-derived cell lines.
Harsh GR; Rosenblum ML; Williams LT
J Neurooncol; 1989 May; 7(1):47-56. PubMed ID: 2547033
[TBL] [Abstract][Full Text] [Related]
40. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
